Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2002 Aug;55(8):575-6.
doi: 10.1136/jcp.55.8.575.

Tissue microarrays for predictive molecular pathology

G Sauter, M Mirlacher
Editorial

Tissue microarrays for predictive molecular pathology

G Sauter et al. J Clin Pathol. 2002 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Influence of number of arrayed samples on tissue microarray (TMA) data. (A) Influence of the number of samples analysed on interpretability of tumours (data from HER-2 immunohistochemistry; HercepTest, Dako). (B) Influence of the number of samples analysed on the percentage of positive tumours (data from HER-2 fluorescence in situ hybridisation; PathVysion, Vysis).
See this image and copyright information in PMC

Comment on

References

    1. Pegram MD, Lipton A, Hayes DF, et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 1998;16:2659–71. - PubMed
    1. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052–6. - PubMed
    1. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844–7. - PubMed
    1. Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72–9. - PubMed
    1. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249–56. - PMC - PubMed

MeSH terms

Substances